ArticlePostepy dermatologii i alergologii2022

Omalizumab in middle-aged or older patients with severe allergic asthma-COPD overlap.

Luisa Ricciardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.